-
HOW ADHERENCE DYNAMICS CHANGE POLICY CONCLUSIONS: MODELING COLORECTAL CANCER SCREENING WITH THE LONGITUDINAL ADHERENCE TRAJECTORY (LAT) FRAMEWORK
Mar 18, 2026, 21:38 PM -
COMPARING AN EXPERT-IN-THE-LOOP AI WORKFLOW WITH MANUAL SYSTEMATIC LITERATURE REVIEW: IMPLICATIONS FOR EFFICIENCY AND EVIDENCE QUALITY IN HEOR
Mar 18, 2026, 21:38 PM -
ELEVATE GEN-AI FRAMEWORK-BASED INTERIM EVALUATION OF A GENAI-ENABLED PLATFORM FOR LITERATURE SCREENING OF A CLASS II MEDICAL DEVICE
Mar 18, 2026, 21:38 PM -
HOW INDIVIDUALS CHOOSE MEDICATIONS: A DISCRETE CHOICE EXPERIMENT TO UNDERSTAND MANAGEMENT OF EYE ALLERGY RX TO OTC TREATMENT DECISIONS
Mar 18, 2026, 21:38 PM -
TREATMENT AFTER CAR T-CELL THERAPY FAILURE IN DIFFUSE LARGE B-CELL LYMPHOMA: HEMATOLOGIST/ONCOLOGISTS’ PERSPECTIVES ON ODRONEXTAMAB AND RESULTS FROM THE ELM-1 STUDY
Mar 18, 2026, 21:38 PM -
AUTOMATING STATISTICAL ANALYSIS PLAN DEVELOPMENT AND DEMOGRAPHIC DESCRIPTIVE ANALYSES IN CLINICAL TRIAL DATA USING GENERATIVE AI
Mar 18, 2026, 21:38 PM -
EVALUATING MODEL PERFORMANCE FOR BETWEEN-COUNTRY SURVIVAL TRANSPORTABILITY
Mar 18, 2026, 21:38 PM -
HEALTHCARE COST ASSOCIATED WITH CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME STAGES AMONG ADULTS IN THE UNITED STATES: ANALYSIS OF NATIONALLY REPRESENTATIVE DATA
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VERSUS DOMAIN-SPECIFIC AI FOR SYSTEMATIC CONFOUNDER IDENTIFICATION IN MULTIPLE SCLEROSIS: A COMPARATIVE METHODOLOGICAL STUDY USING IQWIG ASSESSMENTS AS GROUND TRUTH
Mar 18, 2026, 21:38 PM -
REGULATORY CHALLENGES AND INSIGHTS FROM FDA IN 2025; POTENTIAL IMPLICATIONS OF THE PLAUSIBLE MECHANISM PATHWAY AND SUBSEQUENT HEALTH TECHNOLOGY ASSESSMENTS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF PATIENTS WITH NAMD OR DME WHO MAY REQUIRE MONTHLY DOSING WITH AFLIBERCEPT 8 MG
Mar 18, 2026, 21:38 PM -
ONE GLOBAL EVIDENCE PLAN FOR MANY DECISION-MAKERS: ALIGNING EVIDENCE FOR EU JCA, AMCP DOSSIER, AND ICER REVIEWS
Mar 18, 2026, 21:38 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF ECONOMIC MODELING IN HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS
Mar 18, 2026, 21:38 PM -
REVIEW OF CEESP ICERS FOR ORPHAN AND NON-ORPHAN TREATMENTS IN FRANCE, 2024 - 2025
Mar 18, 2026, 21:38 PM -
LEARNING THE CAUSAL STRUCTURE OF MENTAL HEALTH LITERACY DIMENSIONS FROM OBSERVATIONAL DATA: A MULTI-METHOD CAUSAL DISCOVERY STUDY
Mar 18, 2026, 21:38 PM -
BIREOCICLIB PLUS FULVESTRANT FOR HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS
Mar 18, 2026, 21:38 PM -
FRAILTY AND INFLAMMATION AS PREDICTORS OF MORTALITY IN PATIENTS UNDERGOING ELECTIVE CARDIAC SURGERY
Mar 18, 2026, 21:38 PM -
CLAIMS DATABASE ANALYSIS TO ASSESS THE COMPLEXITY AND SEVERITY OF PATIENT CASES, DISEASE BURDEN, AND HEALTH CARE RESOURCE UTILIZATION (HCRU) IN US BARTH SYNDROME PATIENTS
Mar 18, 2026, 21:38 PM -
THE SCALE OF PROLONGED UNCERTAINTY: ESTIMATING U.S. PATIENT POPULATIONS AFFECTED BY OVERDUE ACCELERATED APPROVAL CONFIRMATORY TRIALS
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE METASLR ROB MODULE: A MULTI-AGENT GENERATIVE AI SYSTEM FOR AUTOMATING COCHRANE RISK OF BIAS 2.0 ASSESSMENTS
Mar 18, 2026, 21:38 PM
